Singapore markets close in 1 hour 5 minutes

Straits Times Index
3,250.93
-9.10(-0.28%)
Nikkei
26,717.34
+547.04(+2.09%)
Hang Seng
23,568.47
-238.53(-1.00%)
FTSE 100
7,554.31
+84.53(+1.13%)
BTC-USD
36,984.46
+803.65(+2.22%)
CMC Crypto 200
838.08
+18.57(+2.27%)

DBS to buy Citi's Taiwan retail business, take over 3,500 staff

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

37.66

-1.79

(-4.54%)

At close: 04:00PM EST

37.97

+0.31

(+0.82%)

After hours:

07:57PM EST

Loading interactive chart…

Zacks
Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Cassava Sciences, Inc. (SAVA) closed at $39.45, marking a -1.42% move from the previous day.
Zacks
Biogen (BIIB) Down on Medicare Draft Ruling for Alzheimer's Drugs
Biogen (BIIB) stock declines after Medicare proposes covering FDA-approved Alzheimer's drugs like Aduhelm only for patients enrolled in qualifying clinical studies.
Motley Fool
Where Will Cassava Sciences Be in 1 Year?
First, the company produced strong results in clinical studies for its potential therapy for Alzheimer's disease (AD), Simufilam. The other reason is the result of Biogen, a competitor, receiving regulatory approval in the U.S. last year for its novel AD treatment -- the first such therapy approved for AD since 2003.